MICHAEL G. KING is a Managing Director and Senior Equity Research
Analyst in the Health Care Group at Banc of America Securities LLC where
he covers the biotechnology sector. He joined Banc of America Securities
in 2002 from Robertson Stephens, where he had been a Managing Director
and Senior Biotechnology Analyst since 1998. Prior to that, he served as
Senior Biotechnology Analyst at Vector Securities from 1996 to 1998 and
at Dillon, Read & Co. from 1994 to 1996. He has also held positions at
D. Blech & Company, Alex. Brown and Sons, Hambrecht & Quist and Kidder,
Peabody & Company. He earned a BBA with honors in Finance from Baruch
College. He was ranked fourth for his stock-picking accuracy in The Wall
Street Journal’s annual ‘Best on the Street’ survey in 2001 and was
given the Institutional Investor Home-Run Hitter award in 2000 for his
coverage of OSI Pharmaceuticals.
Roundtable Forum: Biotechnology
July 28, 2003